Tag: FDA
June 22, 2018
Cannabis Weekly Round-Up: Canada Legalizes Cannabis, Sales Start in October
The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
June 20, 2018
Neovasc Reducer Implanted in First US Patient, Spikes Share Price
The Neovasc Reducer received its CE mark in the European Union in 2011. The company aims to have the device...
June 20, 2018
Cannabis Companies: Stocks on the TSXV
INN offers investors a growing list of all cannabis companies listed on the TSXV. June 15, 2018
Cannabis Weekly Round-Up: The Amendment Fight for Bill C-45
The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the... June 13, 2018
FDA Grants Priority Review to Merck’s Supplemental Biologics License Application (sBLA) for GARDASIL 9
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration...
June 12, 2018
Cannabis Investment: Canadian Cannabis Stocks
The Canadian cannabis space is one of the hottest growing sectors. Are you interested in cannabis investment? Here's a look...
June 10, 2018
5 Top Weekly NASDAQ Biotech Stocks: Caladrius Soars 77 Percent
Caladrius Biosciences, Bellerophon Therapeutics, Celsion, Albireo Pharma and Trillium Therapeutics were last week's top gainers on the NASDAQ Biotechnology Index. June 10, 2018
5 Top Weekly NASDAQ Biotech Stocks: MEI Pharma on Top
MEI Pharma, Anavex Life Sciences, Trillium Therapeutics, Celldex Therapeutics and Ophthotech were last week's top gainers on the NASDAQ Biotechnology... June 8, 2018
Ironwood Pharmaceuticals Announces FDA Orphan Drug Designation for Olinciguat for the Treatment of Sickle Cell Disease
Ironwood Pharmaceuticals (NASDAQ: IRWD), a commercial biotech company, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan... June 7, 2018
